Healthcare Global Enterprises Completes Dispatch of Rights Issue Documents

2 min read     Updated on 06 Mar 2026, 05:48 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Healthcare Global Enterprises Limited completed dispatch of its rights issue Letter of Offer on March 4, 2026, and published mandatory newspaper advertisements on March 6, 2026. The rights issue offers up to 8,294,566 equity shares at ₹512.00 per share, aggregating up to ₹42,468.18 lakhs, in a 1:17 subscription ratio. The issue opens March 11, 2026, and closes March 25, 2026, with mandatory ASBA application process for eligible shareholders.

34345126

*this image is generated using AI for illustrative purposes only.

Healthcare Global Enterprises Limited has completed the dispatch of its Letter of Offer for a significant rights issue, marking a key milestone in the company's capital raising initiative. The oncology-focused healthcare provider published mandatory newspaper advertisements on March 6, 2026, confirming compliance with SEBI regulations for its upcoming rights offering.

Rights Issue Overview

The company's rights issue presents substantial details for eligible shareholders:

Parameter: Details
Issue Size: Up to 8,294,566 equity shares
Face Value: ₹10.00 per share
Issue Price: ₹512.00 per share
Premium: ₹502.00 per share
Total Value: Up to ₹42,468.18 lakhs
Subscription Ratio: 1:17
Record Date: March 2, 2026

Key Timeline and Dates

The rights issue follows a structured timeline with specific dates for various activities:

Event: Date
Issue Opens: March 11, 2026
Last Date for On-Market Renunciation: March 20, 2026
Issue Closes: March 25, 2026
Dispatch Completion: March 4, 2026

Regulatory Compliance and Publication

Healthcare Global Enterprises fulfilled its regulatory obligations by publishing advertisements in three newspapers with wide circulation on March 6, 2026. The publications included Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavanani (Kannada daily newspaper for the regional language of Bengaluru). This publication complies with sub-regulation (1) of Regulation 84 of the SEBI ICDR Regulations.

Application Process and Requirements

The rights issue mandates the use of ASBA (Applications Supported by Blocked Amount) process for all applications. Eligible equity shareholders holding shares in physical form must provide demat account details at least two working days before the issue closing date. The company has arranged with NSDL and CDSL for crediting rights entitlements under ISIN: INE075I01017.

Document Availability and Access

The Letter of Offer dated February 24, 2026, along with application forms and rights entitlement letters, has been dispatched to eligible shareholders. Electronic copies were sent to shareholders who provided valid email addresses, while physical copies were dispatched to Indian addresses on a reasonable effort basis. The documents are accessible on the company's website, registrar's portal, and stock exchange websites.

Trading and Listing Information

Existing equity shares trade on BSE (Scrip Code: 539787) and NSE (Symbol: HCG). Rights entitlements will be tradable in dematerialized form with a market lot of one rights entitlement during the renunciation period from March 11 to March 20, 2026.

HealthCare Global Enterprises Sets March 2, 2026 Record Date for ₹42,500 Lakh Rights Issue

2 min read     Updated on 24 Feb 2026, 08:07 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

HealthCare Global Enterprises has set March 2, 2026 as the record date for its rights issue worth ₹42,500 lakhs, offering 82,94,566 equity shares at ₹512 per share with a 1:17 entitlement ratio. The issue will run from March 11-25, 2026, with comprehensive arrangements for rights entitlement credit and renunciation processes under full regulatory compliance.

33489439

*this image is generated using AI for illustrative purposes only.

HealthCare Global Enterprises Limited has announced the record date of March 2, 2026 for its upcoming rights issue worth ₹42,500.00 lakhs. The company's board of directors, in their meeting held on February 24, 2026, approved the detailed terms and timeline for the equity fundraising initiative under Regulations 30 and 42 of the SEBI Listing Regulations.

Rights Issue Structure and Pricing

The rights issue comprises 82,94,566 fully paid-up equity shares with a face value of ₹10.00 each. The company has set the rights issue price at ₹512.00 per share, which includes a premium of ₹502.00 per equity share.

Parameter: Details
Total Shares Offered: 82,94,566
Issue Price: ₹512.00 per share
Premium: ₹502.00 per share
Face Value: ₹10.00 per share
Total Amount: ₹42,468.18 lakhs
Rights Ratio: 1:17

Entitlement and Record Date Details

Shareholders holding equity shares as on the record date of March 2, 2026 will be entitled to participate in the rights issue. The entitlement ratio has been set at 1 rights equity share for every 17 fully paid-up equity shares held on the record date. Rights entitlements will be credited to eligible shareholders' demat accounts under ISIN INE075I20017 prior to the issue opening date.

Issue Timeline and Key Dates

The rights issue follows a structured timeline spanning from March 2026 to April 2026:

Event: Date
Record Date: Monday, March 2, 2026
Last Date for Credit of Rights Entitlements: Wednesday, March 4, 2026
Issue Opening Date: Wednesday, March 11, 2026
Last Date for On-Market Renunciation: Friday, March 20, 2026
Issue Closing Date: Wednesday, March 25, 2026
Finalisation of Basis of Allotment: Friday, March 27, 2026
Date of Allotment: Friday, March 27, 2026
Date of Credit of Rights Equity Shares: Monday, March 30, 2026
Date of Listing of Rights Equity Shares: Wednesday, April 1, 2026

Renunciation and Application Process

Rights entitlement holders can renounce their rights either through on-market renunciation via stock exchanges or through off-market transfers. The company has made arrangements with NSDL and CDSL for crediting rights entitlements to eligible shareholders' demat accounts. To receive allotment, rights entitlement holders must submit applications by the issue closing date with full payment. If no application is made by the issue closing date, the rights entitlements will lapse.

Impact on Share Capital

The rights issue will increase the company's outstanding equity shares from 141,007,637 shares to 149,302,203 shares, assuming full subscription. The board retains the right to extend the issue period up to 30 days from the opening date if required.

Regulatory Compliance

The rights issue has been structured in accordance with the Companies Act 2013, SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, and SEBI Listing Regulations. The company will file the Letter of Offer with SEBI, BSE Limited, and National Stock Exchange of India Limited as part of the regulatory process. The board meeting commenced at 5.00 p.m. and completed at 7.50 p.m. on February 24, 2026.

More News on Healthcare Global Enterprises